Drug Manufacturers—Specialty & Generic Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2278 |  PAHC Phibro Animal Health Corporation - Class A Common Stock | 32.42 USD | -2.11% | +3.31% | +0.78% | +6.36% | 1.32 B USD | ||
| 2373 |  COLL Collegium Pharmaceutical, Inc. - Common Stock | 36.49 USD | +0.14% | -0.46% | +8.25% | +3.84% | 1.18 B USD | ||
| 2434 |  ALVO Alvotech - Ordinary Shares | 3.45 USD | -1.15% | -6.25% | -20.32% | -59.22% | 1.08 B USD | ||
| 2437 |  BIOA BioAge Labs, Inc. - Common Stock | 24.24 USD | -0.66% | -0.53% | +56.29% | +218.95% | 1.08 B USD | ||
| 2461 |  ETON Eton Pharmaceuticals, Inc. - Common Stock | 37.06 USD | -1.80% | +1.51% | +22.23% | +133.96% | 1.02 B USD | ||
| 2466 |  CRON Cronos Group Inc. - Common Share | 2.75 USD | 0.00% | -4.18% | -1.08% | +32.21% | 1.03 B USD | ||
| 2474 |  PCRX Pacira BioSciences, Inc. - Common Stock | 25.58 USD | -0.93% | +0.16% | +11.22% | +17.18% | 1.01 B USD | ||
| 2479 |  EVO Evotec SE - American Depositary Shares each representing 1/2 of | 2.77 USD | -2.81% | -4.48% | 0.00% | -35.13% | 984.90 M USD | ||
| 2567 |  AMPH Amphastar Pharmaceuticals, Inc. - Common Stock | 19.59 USD | -2.44% | -4.39% | -0.76% | -19.65% | 863.78 M USD | ||
| 2619 |  ESPR Esperion Therapeutics, Inc. - Common Stock | 3.18 USD | +0.63% | +0.32% | +1.27% | +169.49% | 818.63 M USD | ||
| 2677 |  IRWD Ironwood Pharmaceuticals, Inc. - Class A Common Stock | 4.85 USD | +8.50% | +16.87% | +48.32% | +546.67% | 798.38 M USD | ||
| 2879 |  AQST Aquestive Therapeutics, Inc. - Common Stock | 4.32 USD | -0.23% | +1.65% | +9.64% | +16.13% | 541.94 M USD | ||
| 2927 |  TLRY Tilray Brands, Inc. - Common Stock | 4.34 USD | +0.70% | -0.23% | -13.55% | +611.48% | 505.82 M USD | ||
| 2997 |  EOLS Evolus, Inc. - Common Stock | 7.06 USD | +1.73% | +2.47% | +4.59% | -24.81% | 464.93 M USD | ||
| 3050 |  EBS Emergent BioSolutions Inc. Common Stock | 8.16 USD | -1.69% | -3.77% | +0.99% | -23.88% | 421.03 M USD | ||
| 3065 |  KMDA Kamada Ltd. - Ordinary Shares | 7.34 USD | +0.41% | -4.30% | +0.82% | -5.29% | 423.42 M USD | ||
| 3105 |  CGC Canopy Growth Corporation - Common Shares | 0.96 USD | +1.05% | +1.05% | -5.88% | -23.20% | 405.27 M USD | ||
| 3182 |  AKBA Akebia Therapeutics, Inc. - Common Stock | 1.37 USD | +0.74% | +15.13% | +44.21% | +16.10% | 367.51 M USD | ||
| 3288 |  ORGO Organogenesis Holdings Inc. - Class A | 2.46 USD | -1.60% | +2.93% | +3.36% | -42.66% | 316.54 M USD | ||
| 3396 |  TKNO Alpha Teknova, Inc. - Common Stock | 5.07 USD | -6.63% | -13.18% | +9.03% | +0.40% | 271.82 M USD |
Nouvelles Drug Manufacturers—Specialty & Generic Stocks
PRF Technologies finalise la phase de validation de sa plateforme IA pour l’énergie
Opaleye Management vend pour 4,77 M$ d’actions Eton Pharmaceuticals (ETON)
Teva présente des premières données sur la repigmentation précoce de la peau, prépare le terrain pour la prochaine étude | Benzinga France
Le titre d’Eton Pharmaceuticals atteint un sommet historique à 38,6 USD
Teva fait progresser son anticorps anti-IL-15 en Phase 2b pour le vitiligo
60% de réduction sur InvestingPro : le prix le plus bas de 2026 pour une durée limitée
Le SVP et CFO d’Ani Pharmaceuticals vend des actions pour 284 000 $
Gainers Drug Manufacturers—Specialty & Generic Stocks
Losers Drug Manufacturers—Specialty & Generic Stocks
 BFRIW Biofrontera Inc. - Warrants | 0.0220 | -23.34% |
 AKAN Akanda Corp. - Common Shares | 10.52 | -7.88% |
TKNO Alpha Teknova, Inc. - Common Stock | 5.07 | -6.63% |
 IMCC IM Cannabis Corp. - Common Shares | 0.15 | -6.25% |
 IXHL Incannex Healthcare Inc. - Common Stock | 3.48 | -6.20% |
 BGM BGM Group Ltd. - Class A Ordinary Shares | 0.31 | -6.06% |
 PRFX PRF Technologies Ltd. - Ordinary Shares | 1.27 | -5.22% |
 ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 0.73 | -5.19% |